FOLH1 and cancer: Prostate MRI in this same cohort has previously been shown to have sensitivity of 0.72–0.76, specificity 0.64–0.65, PPV 0.74–0.76, and NPV 0.59–0.67 depending on cancer definition used.21 When prostate MRI and [68Ga]Ga-PSMA-11 PET/CT, scored using a Likert system, were interpreted in conjunction, there were statistically significant increases in sensitivity to 0.97–0.98 and in NPV to 0.93.